Featured Image of Top News Story: RSV vaccine protects older adults against severe illness

RSV vaccine protects older adults against severe illness

A new study by Kaiser Permanente has shown that the ABRYSVO respiratory syncytial virus vaccine is very effective in reducing emergency room visits and hospital stays due to RSV among older adults. “This Kaiser Permanente research demonstrated the real-world effectiveness of RSV vaccination among ...

  • Study links youth firearm injuries to certain risk factors

    October 21, 2022
    A study of nearly 2 million pediatric Kaiser Permanente members reinforces known links between children’s chances of experiencing a firearm injury and certain risk factors — especially being an adolescent male. The study, which appeared recently in Academic Pediatrics, addresses a number of additional risk factors, providing a broad view of the risk of firearm ...
    Read more...
  • Exposure to air pollution worsens COVID-19 outcomes, even among the fully vaccinated

    October 21, 2022
    COVID-19 is a respiratory illness, so it’s not surprising that exposure to poor air quality worsens patient outcomes. But how does air pollution affect people who are vaccinated? To answer that question, a team of researchers analyzed data from more than 50,000 Kaiser Permanente Southern California COVID-19 patients. By comparing publicly available air quality monitoring data ...
    Read more...
  • We have job openings

    October 21, 2022
    Are you looking for an opportunity to make a real difference in health? As a research program embedded within an integrated health care system, the Department of Research & Evaluation provides a rare career opportunity for those who want to use research to help solve real-world health care challenges. To learn more about career opportunities, ...
    Read more...
  • Chronic metabolic conditions affect metastatic breast cancer survival rates

    October 6, 2022
    Early detection and screening of breast cancer has allowed most women to thrive long after their diagnosis. However, women of color persistently experience disparities in outcomes. Researchers at the Kaiser Permanente Southern California Department of Research & Evaluation have been working to find ways to reduce these disparities and improve the survival rates for all ...
    Read more...
  • 5 questions for … Dr. Amrita Mukherjee

    September 21, 2022
    Amrita Mukherjee, PhD, MPH, is an epidemiologist in the first year of her postdoctoral program at the Kaiser Permanente Southern California Department of Research & Evaluation. Her research interests include human papillomavirus-associated cancers, gynecologic cancers, comorbidities in cancer patients and survivors, and development of risk prediction models using electronic health records and cancer registry data. ...
    Read more...
  • 5 questions for … Dr. Nana Mensah

    September 19, 2022
    A maternal and child health epidemiologist, Nana Mensah, PhD, MPH, is in the first year of her postdoctoral program at the Kaiser Permanente Southern California Department of Research & Evaluation. Through her research working with the Kaiser Permanente Southern California Pregnancy Registry, she seeks to understand how clinical guidelines and practices shape birth outcomes in ...
    Read more...
  • 5 questions for … Dr. Lewei Duan

    September 16, 2022
    A health economist, Lewei Duan, PhD, MS, is a postdoctoral research fellow at the Kaiser Permanente Southern California Department of Research & Evaluation. She has special interests in improving health care delivery systems, specifically in maximizing health and well-being for older adults and underserved populations. Prior to her current position, Dr. Duan worked as a ...
    Read more...
  • Remdesivir may reduce hospital readmissions for COVID-19 patients

    September 15, 2022
    A study of Kaiser Permanente Southern California members who were hospitalized for COVID-19 identifies key factors associated with lower chances of readmission — including treatment with the medication remdesivir and delaying discharge until 10 days have passed since COVID-19 symptoms began. “This study supports a continued role for remdesivir in treating COVID-19,” said the study’s lead ...
    Read more...
  • Antidepressants linked to lower risk of prostate cancer recurrence

    September 9, 2022
    In a study of more than 10,000 Kaiser Permanente members diagnosed with both prostate cancer and depression, those who used antidepressants had a lower risk of cancer recurrence. These findings appeared September 9, 2022, in Cancer Causes & Control. “Our research highlights how important it is for patients with prostate cancer to be screened and treated ...
    Read more...
  • Fewer hospitalizations for home-based cardiac rehabilitation patients

    August 25, 2022
    Patients who participated in in-home cardiac rehabilitation had fewer hospitalizations over 12 months than patients who participated in center-based cardiac rehabilitation, according to a Kaiser Permanente study published August 25, 2022, in JAMA Network Open. “The remarkable thing we found in this study of more than 2,500 diverse patients was that health advantages of home-based cardiac ...
    Read more...